Life Sciences

Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.

Medisolv Acquires Health Elements AI to Expand Clinical Data Capabilities

Medisolv has acquired Health Elements AI to improve how healthcare organizations capture and use clinical data for quality reporting and registries. The acquisition aims to reduce manual chart review workloads and broaden Medisolv's analytics capabilities.

April 30, 2026

SanLuca and Sutter Health Integrate AI Behavioral Support in Hypertension Care

SanLuca has partnered with Sutter Health to integrate cognitive behavioral therapy into hypertension management through the Sutter Sync program, combining AI-led virtual care with clinical oversight to support behavioral and physical health outcomes.

April 30, 2026

AiZtech Labs Launches iSelfie BioSignals for Smartphone-Based Patient Assessment

AiZtech Labs has launched iSelfie BioSignals in the U.S., a smartphone-based platform that captures clinical data through selfies to assist healthcare providers with faster triage and intake.

April 30, 2026

ProviderTrust and J.D. Palatine Partner to Streamline Healthcare Hiring Compliance

ProviderTrust and J.D. Palatine have announced a partnership to integrate background checks and eligibility verification into healthcare hiring, improving compliance and efficiency.

April 30, 2026

Hippocratic AI Introduces Polaris 5.0, Evidence-Based Healthcare Model

Hippocratic AI has launched Polaris 5.0, a healthcare-focused AI model built on 180 million patient interactions. The system outperforms models from OpenAI, Anthropic, and Google in clinical accuracy, safety, and empathy for voice-based medical applications.

April 30, 2026

Photon Raises $16 Million Series A to Expand AI Prescription Infrastructure

Photon has raised $16 million in a Series A round led by Healthier Capital, with participation from Notation, Flare Capital Partners, and Evidenced. The funding will support team expansion, platform integrations, and the development of its AI-based prescription infrastructure.

April 30, 2026

Singular Genomics Appoints John Stark as CEO

Singular Genomics Systems has appointed John Stark as Chief Executive Officer as the company expands its spatial genomics platform and focuses on broader adoption in translational research and clinical applications.

April 30, 2026

Rad AI Names David Leonard COO and Elizabeth Bergey CCO

Rad AI has appointed David Leonard as Chief Operating Officer and Dr. Elizabeth Bergey as its first Chief Clinical Officer, strengthening its operational and clinical leadership as it expands its radiology reporting solutions.

April 30, 2026

Carrum Health Names New Tech Leaders to Expand AI and Data Capabilities

Carrum Health has appointed Kulesh Shanmugasundaram as Chief Product and Technology Officer and Ravi Garimella as Senior Vice President of Data and AI to strengthen its AI and data infrastructure as the company scales its specialty care platform.

April 30, 2026

Arizton Projects Europe Laboratory Information Systems Market to Reach $689 Million by 2031

Arizton forecasts that the Europe laboratory information systems market will reach USD 689.05 million by 2031, driven by AI adoption and digital modernization in laboratory operations.

April 30, 2026

Haier Biomedical Reports Record Overseas Revenue in 2025 Annual Results

Haier Biomedical reported 2025 annual revenue of 2.33 billion yuan, with overseas operations contributing a record 36 percent of total revenue. The company highlighted growth in AI applications, new product certifications, and expanded global presence.

April 30, 2026

Diagens Reports 134% Annual Revenue Growth Driven by Medical Imaging Model

Hangzhou-based Diagens reported RMB 164 million in annual revenue for its first year since listing, a 133.7% increase, with licensing from its iMedImage foundation model emerging as the main growth driver.

April 30, 2026

Caris Life Sciences Validates AI Model for Temozolomide Response in Glioblastoma

Caris Life Sciences has published a peer-reviewed study validating its AI-based predictive signature for temozolomide benefit in glioblastoma patients, showing strong concordance with traditional MGMT methylation testing.

April 29, 2026

Valeris and Fuze Health Partner to Modernize Patient Access Model

Valeris and Fuze Health have agreed to collaborate on integrating digital pharmacy capabilities with patient access and support services. The partnership aims to accelerate therapy initiation and improve coordination across the patient journey.

April 29, 2026

Zingage Integrates AI Agents with HHAeXchange Network

Zingage has integrated its AI agents with HHAeXchange’s Partner Connect program, giving over 32,000 home care providers access to automation tools for scheduling, phone operations, and compliance management.

April 29, 2026

SnapCare and connectRN Merge to Expand Healthcare Workforce Solutions

SnapCare and connectRN have merged to address healthcare staffing challenges, combining their platforms and clinician networks. The new company also secured Series A funding led by Suvretta Capital to support product innovation and growth.

April 29, 2026

RIVANNA Study Shows Non-Physicians Can Operate Accuro XV for Musculoskeletal Imaging

RIVANNA reported that its Accuro XV ultrasound system produced diagnostic-quality images of extremity injuries when used by non-physicians after brief training, according to a published study.

April 29, 2026

Complete Genomics Reports 73% Fewer Genome Analysis Errors with AI Models

Complete Genomics announced that AI trained variant calling models reduced genome analysis errors by up to 73 percent compared to standard methods on its DNBSEQ sequencing platform.

April 29, 2026

DeepLook Medical Wins Top Prize at Venture Madness 2026

DeepLook Medical has won top honors at the 2026 Venture Madness competition for its AI imaging technology that enhances early cancer detection. The company, supported by Xcellerant Ventures, has expanded its operations in Arizona and will conduct upcoming clinical trials with Banner MD Anderson.

April 29, 2026

Paradigm Health and FDA Begin Collaboration on Real Time Clinical Trial Review

Paradigm Health has launched a collaboration with the FDA to develop a model for real time regulatory review of clinical trial data. The project involves trials sponsored by Amgen and AstraZeneca and aims to automate data collection and reporting to speed up reviews.

April 28, 2026

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.